UBIO
Proshares UltraPro NASDAQ Biotechnology
UBIO
UBIO
Delisted
UBIO was delisted on the 27th of March, 2020.
6 hedge funds and large institutions have $1.25M invested in Proshares UltraPro NASDAQ Biotechnology in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less call options, than puts
Call options by funds: $ | Put options by funds: $
63% less capital invested
Capital invested by funds: $3.4M → $1.25M (-$2.15M)
Holders
6
Holding in Top 10
–
Calls
$239K
Puts
$506K
Top Buyers
| 1 | +$721K | |
| 2 | +$23K | |
| 3 | +$19.4K | |
| 4 |
AIM
Anchor Investment Management
Columbia,
South Carolina
|
+$8.75K |
Top Sellers
| 1 | -$1.28M | |
| 2 | -$818K | |
| 3 | -$527K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$155K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$101K |